Skip to main content
PMC home page
The EMBO Journal logoLink to The EMBO Journal
. 1988 Sep;7(9):2861–2867. doi: 10.1002/j.1460-2075.1988.tb03142.x

Structure-function relationships in the GTP binding domain of EF-Tu: mutation of Val20, the residue homologous to position 12 in p21.

E Jacquet 1, A Parmeggiani 1
PMCID: PMC457079  PMID: 3181143

Abstract

Val20 of elongation factor Tu (EF-Tu), one of the best-characterized GTP binding proteins, is a variable residue within the consensus motif G-X-X-X-X-G-K involved in the interaction with the phosphates of GDP/GTP. To investigate the structure-function relationships of EF-Tu, which is widely used as a model protein, Val20 has been substituted by Gly using oligonucleotide-directed mutagenesis. The most important effects are: (i) a strong reduction of the intrinsic GTPase activity, (ii) a remarkable enhancement of the association and dissociation rates of EF-TuGly20-GDP, mimicking the effect of elongation factor Ts (EF-Ts) and (iii) the inability of ribosomes to influence the intrinsic GTPase of EF-Tu uncoupled from poly(Phe) synthesis. EF-TuGly20 can sustain poly(Phe) synthesis, albeit at a much lower rate than wild-type EF-TuVal20. As with the latter, poly(Phe) synthesis by EF-TuGly20 is inhibited by the antibiotic kirromycin, but differs remarkably in that it is largely independent of the presence of EF-Ts. According to primary sequence alignment, position 20 is homologous to position 12 of ras protein p21. As in p21, this position in EF-Tu is critical, influencing specifically the GDP/GTP interaction as well as other functions. The effect of the mutation displays diversities but also similarities with the situation reported for p21 having the corresponding residues in position 12. The differences observed with two homologous residues, Gly20 and Gly12 in EF-Tu and p21 respectively, show the importance of a variable residue in a consensus element in defining specific functions of GTP binding proteins.

Full text

PDF
2861

Images in this article

2862Image
on p.2862

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbacid M. ras genes. Annu Rev Biochem. 1987;56:779–827. doi: 10.1146/annurev.bi.56.070187.004023. [DOI] [PubMed] [Google Scholar]
  2. Bosch L., Kraal B., Van der Meide P. H., Duisterwinkel F. J., Van Noort J. M. The elongation factor EF-Tu and its two encoding genes. Prog Nucleic Acid Res Mol Biol. 1983;30:91–126. doi: 10.1016/s0079-6603(08)60684-4. [DOI] [PubMed] [Google Scholar]
  3. Cenatiempo Y., Deville F., Dondon J., Grunberg-Manago M., Sacerdot C., Hershey J. W., Hansen H. F., Petersen H. U., Clark B. F., Kjeldgaard M. The protein synthesis initiation factor 2 G-domain. Study of a functionally active C-terminal 65-kilodalton fragment of IF2 from Escherichia coli. Biochemistry. 1987 Aug 11;26(16):5070–5076. doi: 10.1021/bi00390a028. [DOI] [PubMed] [Google Scholar]
  4. Chinali G., Wolf H., Parmeggiani A. Effect of kirromycin on elongation factor Tu. Location of the catalytic center for ribosome-elongation-factor-Tu GTPase activity on the elongation factor. Eur J Biochem. 1977 May 2;75(1):55–65. doi: 10.1111/j.1432-1033.1977.tb11503.x. [DOI] [PubMed] [Google Scholar]
  5. Crechet J. B., Parmeggiani A. Characterization of the elongation factors from calf brain. 2. Functional properties of EF-1 alpha, the action of physiological ligands and kirromycin. Eur J Biochem. 1986 Dec 15;161(3):647–653. doi: 10.1111/j.1432-1033.1986.tb10489.x. [DOI] [PubMed] [Google Scholar]
  6. Dente L., Cesareni G., Cortese R. pEMBL: a new family of single stranded plasmids. Nucleic Acids Res. 1983 Mar 25;11(6):1645–1655. doi: 10.1093/nar/11.6.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dever T. E., Glynias M. J., Merrick W. C. GTP-binding domain: three consensus sequence elements with distinct spacing. Proc Natl Acad Sci U S A. 1987 Apr;84(7):1814–1818. doi: 10.1073/pnas.84.7.1814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Duisterwinkel F. J., Kraal B., De Graaf J. M., Talens A., Bosch L., Swart G. W., Parmeggiani A., La Cour T. F., Nyborg J., Clark B. F. Specific alterations of the EF-Tu polypeptide chain considered in the light of its three-dimensional structure. EMBO J. 1984 Jan;3(1):113–120. doi: 10.1002/j.1460-2075.1984.tb01770.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fasano O., Bruns W., Crechet J. B., Sander G., Parmeggiani A. Modification of elongation-factor-Tu . guanine-nucleotide interaction by kirromycin. A comparison with the effect of aminoacyl-tRNA and elongation factor Ts. Eur J Biochem. 1978 Sep 1;89(2):557–565. doi: 10.1111/j.1432-1033.1978.tb12560.x. [DOI] [PubMed] [Google Scholar]
  10. Fasano O., De Vendittis E., Parmeggiani A. Hydrolysis of GTP by elongation factor Tu can be induced by monovalent cations in the absence of other effectors. J Biol Chem. 1982 Mar 25;257(6):3145–3150. [PubMed] [Google Scholar]
  11. Fry D. C., Kuby S. A., Mildvan A. S. ATP-binding site of adenylate kinase: mechanistic implications of its homology with ras-encoded p21, F1-ATPase, and other nucleotide-binding proteins. Proc Natl Acad Sci U S A. 1986 Feb;83(4):907–911. doi: 10.1073/pnas.83.4.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gibbs J. B., Sigal I. S., Poe M., Scolnick E. M. Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules. Proc Natl Acad Sci U S A. 1984 Sep;81(18):5704–5708. doi: 10.1073/pnas.81.18.5704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gilman A. G. G proteins: transducers of receptor-generated signals. Annu Rev Biochem. 1987;56:615–649. doi: 10.1146/annurev.bi.56.070187.003151. [DOI] [PubMed] [Google Scholar]
  14. Ivell R., Sander G., Parmeggiani A. Modulation by monovalent and divalent cations of the guanosine-5'-triphosphatase activity dependent on elongation factor Tu. Biochemistry. 1981 Nov 24;20(24):6852–6859. doi: 10.1021/bi00527a017. [DOI] [PubMed] [Google Scholar]
  15. Jurnak F. Structure of the GDP domain of EF-Tu and location of the amino acids homologous to ras oncogene proteins. Science. 1985 Oct 4;230(4721):32–36. doi: 10.1126/science.3898365. [DOI] [PubMed] [Google Scholar]
  16. Kramer W., Schughart K., Fritz H. J. Directed mutagenesis of DNA cloned in filamentous phage: influence of hemimethylated GATC sites on marker recovery from restriction fragments. Nucleic Acids Res. 1982 Oct 25;10(20):6475–6485. doi: 10.1093/nar/10.20.6475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Masters S. B., Stroud R. M., Bourne H. R. Family of G protein alpha chains: amphipathic analysis and predicted structure of functional domains. Protein Eng. 1986 Oct-Nov;1(1):47–54. [PubMed] [Google Scholar]
  18. McCormick F., Clark B. F., la Cour T. F., Kjeldgaard M., Norskov-Lauritsen L., Nyborg J. A model for the tertiary structure of p21, the product of the ras oncogene. Science. 1985 Oct 4;230(4721):78–82. doi: 10.1126/science.3898366. [DOI] [PubMed] [Google Scholar]
  19. McGrath J. P., Capon D. J., Goeddel D. V., Levinson A. D. Comparative biochemical properties of normal and activated human ras p21 protein. Nature. 1984 Aug 23;310(5979):644–649. doi: 10.1038/310644a0. [DOI] [PubMed] [Google Scholar]
  20. Parlato G., Pizzano R., Picone D., Guesnet J., Fasano O., Parmeggiani A. Different regions of aminoacyl-tRNA regulate the function of elongation factor Tu. J Biol Chem. 1983 Jan 25;258(2):995–1000. [PubMed] [Google Scholar]
  21. Parmeggiani A., Swart G. W. Mechanism of action of kirromycin-like antibiotics. Annu Rev Microbiol. 1985;39:557–577. doi: 10.1146/annurev.mi.39.100185.003013. [DOI] [PubMed] [Google Scholar]
  22. Parmeggiani A., Swart G. W., Mortensen K. K., Jensen M., Clark B. F., Dente L., Cortese R. Properties of a genetically engineered G domain of elongation factor Tu. Proc Natl Acad Sci U S A. 1987 May;84(10):3141–3145. doi: 10.1073/pnas.84.10.3141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Remaut E., Tsao H., Fiers W. Improved plasmid vectors with a thermoinducible expression and temperature-regulated runaway replication. Gene. 1983 Apr;22(1):103–113. doi: 10.1016/0378-1119(83)90069-0. [DOI] [PubMed] [Google Scholar]
  24. Satoh T., Nakamura S., Nakafuku M., Kaziro Y. Studies on ras proteins. Catalytic properties of normal and activated ras proteins purified in the absence of protein denaturants. Biochim Biophys Acta. 1988 Jan 25;949(1):97–109. doi: 10.1016/0167-4781(88)90059-0. [DOI] [PubMed] [Google Scholar]
  25. Seeburg P. H., Colby W. W., Capon D. J., Goeddel D. V., Levinson A. D. Biological properties of human c-Ha-ras1 genes mutated at codon 12. Nature. 1984 Nov 1;312(5989):71–75. doi: 10.1038/312071a0. [DOI] [PubMed] [Google Scholar]
  26. Swart G. W., Parmeggiani A., Kraal B., Bosch L. Effects of the mutation glycine-222----aspartic acid on the functions of elongation factor Tu. Biochemistry. 1987 Apr 7;26(7):2047–2054. doi: 10.1021/bi00381a038. [DOI] [PubMed] [Google Scholar]
  27. Tabin C. J., Bradley S. M., Bargmann C. I., Weinberg R. A., Papageorge A. G., Scolnick E. M., Dhar R., Lowy D. R., Chang E. H. Mechanism of activation of a human oncogene. Nature. 1982 Nov 11;300(5888):143–149. doi: 10.1038/300143a0. [DOI] [PubMed] [Google Scholar]
  28. Taparowsky E., Suard Y., Fasano O., Shimizu K., Goldfarb M., Wigler M. Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature. 1982 Dec 23;300(5894):762–765. doi: 10.1038/300762a0. [DOI] [PubMed] [Google Scholar]
  29. Trahey M., Milley R. J., Cole G. E., Innis M., Paterson H., Marshall C. J., Hall A., McCormick F. Biochemical and biological properties of the human N-ras p21 protein. Mol Cell Biol. 1987 Jan;7(1):541–544. doi: 10.1128/mcb.7.1.541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tucker J., Sczakiel G., Feuerstein J., John J., Goody R. S., Wittinghofer A. Expression of p21 proteins in Escherichia coli and stereochemistry of the nucleotide-binding site. EMBO J. 1986 Jun;5(6):1351–1358. doi: 10.1002/j.1460-2075.1986.tb04366.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Van Noort J. M., Kraal B., Bosch L., La Cour T. F., Nyborg J., Clark B. F. Cross-linking of tRNA at two different sites of the elongation factor Tu. Proc Natl Acad Sci U S A. 1984 Jul;81(13):3969–3972. doi: 10.1073/pnas.81.13.3969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Van der Meide P. H., Borman T. H., Van Kimmenade A. M., Van de Putte P., Bosch L. Elongation factor Tu isolated from Escherichia coli mutants altered in TufA and tufB. Proc Natl Acad Sci U S A. 1980 Jul;77(7):3922–3926. doi: 10.1073/pnas.77.7.3922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wittinghofer A., Frank R., Leberman R. Composition and properties of trypsin-cleaved elongation factor Tu. Eur J Biochem. 1980 Jul;108(2):423–431. doi: 10.1111/j.1432-1033.1980.tb04738.x. [DOI] [PubMed] [Google Scholar]
  34. de Vos A. M., Tong L., Milburn M. V., Matias P. M., Jancarik J., Noguchi S., Nishimura S., Miura K., Ohtsuka E., Kim S. H. Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21. Science. 1988 Feb 19;239(4842):888–893. doi: 10.1126/science.2448879. [DOI] [PubMed] [Google Scholar]
  35. la Cour T. F., Nyborg J., Thirup S., Clark B. F. Structural details of the binding of guanosine diphosphate to elongation factor Tu from E. coli as studied by X-ray crystallography. EMBO J. 1985 Sep;4(9):2385–2388. doi: 10.1002/j.1460-2075.1985.tb03943.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. van der Meide P. H., Vijgenboom E., Talens A., Bosch L. The role of EF-Tu in the expression of tufA and tufB genes. Eur J Biochem. 1983 Feb 1;130(2):397–407. doi: 10.1111/j.1432-1033.1983.tb07166.x. [DOI] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES